Company research
Mosaic ImmunoEngineering Inc.
CIK 836564Updated Nov 16, 2026
SecurityCPMV · OTC · equity
Historical securities (2)
PTSC · OTC · equity · closed Dec 2, 2020PTSCD · OTC · equity · closed Dec 31, 2020Name history
PATRIOT SCIENTIFIC CORP · through Nov 19, 2020
CPMV price & chart
Loading TradingView…
OTC:CPMV on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2020 | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q1 2021 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,044,588Source | 19,882Source | 141,611Source | 179,533Source | 261,277Source | 269,494Source | 482,488Source | 616,534Source | 19,882Source | 141,611Source | 179,533Source | 261,277Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 748,829Source | 3,622Source | 115,019Source | 156,178Source | 220,645Source | 226,142Source | 412,526Source | 373,378Source | 3,622Source | 115,019Source | 156,178Source | 220,645Source |
| Assets, CurrentUSD | 1,009,737Source | 19,882Source | 141,611Source | 179,533Source | 261,277Source | 269,494Source | 482,488Source | 616,534Source | 19,882Source | 141,611Source | 179,533Source | 261,277Source |
| Prepaid Expense and Other Assets, CurrentUSD | — | 16,260Source | — | — | — | — | — | — | 16,260Source | — | — | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 305,679Source | 7,495,902Source | 6,929,785Source | 6,050,591Source | 5,146,035Source | 3,068,505Source | 855,420Source | 358,423Source | 7,495,902Source | 6,929,785Source | 6,050,591Source | 5,146,035Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 4,382Source | 72Source | 72Source | 72Source | 72Source | 72Source | 8Source | 4,014Source | 72Source | 72Source | 72Source | 72Source |
| Additional Paid in CapitalUSD | 77,444,062Source | 2,050,073Source | 2,050,073Source | 2,045,206Source | 2,023,271Source | 1,728,148Source | 374,490Source | 370,484Source | 2,050,073Source | 2,050,073Source | 2,045,206Source | 2,023,271Source |
| Retained Earnings (Accumulated Deficit)USD | -62,083,667Source | -9,526,166Source | -8,838,320Source | -7,916,337Source | -6,908,102Source | -4,527,232Source | -747,437Source | -116,394Source | -9,526,166Source | -8,838,320Source | -7,916,337Source | -6,908,102Source |
| Stockholders' Equity Attributable to ParentUSD | 738,909Source | -7,476,020Source | -6,788,174Source | -5,871,058Source | -4,884,758Source | -2,799,011Source | -422,541Source | 258,111Source | -7,476,020Source | -6,788,174Source | -5,871,058Source | -4,884,758Source |
| Liabilities and EquityUSD | 1,044,588Source | 19,882Source | 141,611Source | 179,533Source | 261,277Source | 269,494Source | 482,488Source | 616,534Source | 19,882Source | 141,611Source | 179,533Source | 261,277Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 305,679Source | 6,030,055Source | 5,537,270Source | 4,733,055Source | 3,917,674Source | 2,333,357Source | 855,420Source | 358,423Source | 6,030,055Source | 5,537,270Source | 4,733,055Source | 3,917,674Source |
| Accounts Payable, CurrentUSD | 24,434Source | 132,784Source | 134,865Source | 118,478Source | 133,464Source | 113,513Source | 52,197Source | 24,974Source | 132,784Source | 134,865Source | 118,478Source | 133,464Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 281,245Source | 655,160Source | 646,850Source | 641,763Source | 584,808Source | 724,247Source | 668,571Source | 194,172Source | 655,160Source | 646,850Source | 641,763Source | 584,808Source |
| Property, Plant and Equipment, Net | —Source | — | — | — | — | — | — | — | — | — | — | — |
| Preferred Stock, Value, Issued | —Source | — | — | — | — | — | —Source | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2020 | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q1 2021 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | — | 0Source | 4,867Source | 21,935Source | 295,123Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | — | -55,156Source | -111,397Source | -241,159Source | -497,467Source | -690,129Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | 605,215Source | — | 0Source | 433,000Source | 343,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | — | 63Source | 0Source | 200,000Source | 0Source | 341,632Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 3,622Source | 115,019Source | 156,178Source | 220,645Source | 226,142Source | 352,738Source | 550,622Source | 3,622Source | 115,019Source | 156,178Source | 220,645Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 0Source | 6,214Source | 0Source | 0Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | 0Source | 2,400Source | 2,400Source | 2,400Source | 2,400Source |
| Additional Financial Items | ||||||||||||
| Accretion ExpenseUSD | — | — | — | — | — | — | — | — | 0Source | 1,446Source | 15,842Source | 81,843Source |
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | 0Source | 4,867Source | 21,935Source | 295,123Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | — | — | — | — | — | — | — | — | 46,700Source | 57,600Source |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | 376,313Source | 28,300Source | 552,138Source | 695,788Source | 964,319Source | 1,579,065Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 1,600Source | 0Source | 2,400Source | 2,400Source | 2,400Source | 2,400Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | — | — | — | — | -631,043Source | -115,883Source | -687,846Source | -921,983Source | -1,008,235Source | -2,380,870Source |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | -983Source | -4,076Source | -69,327Source | -39,928Source | 393,933Source | 249,052Source |
| Operating ExpensesUSD | — | — | — | — | — | — | 628,460Source | 111,807Source | 616,119Source | 879,655Source | 1,399,768Source | 2,627,522Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | — | 0Source | 270,000Source | — | — |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | — | — | — | — | — | — | — | 0Source | — | — |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Proceeds from Issuance of Common Stock | — | — | — | — | — | — | — | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2020 | Q4 2019 | Q3 2020 | Q3 2019 | Q2 2021 | Q2 2020 | Q1 2021 | Q1 2020 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | — | — | — | — | — | — | -616,119Source | -879,655Source | -1,399,768Source | -2,627,522Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -685,446Source | -919,583Source | -1,005,835Source | -2,378,470Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 1,600Source | 0Source | 0Source | 1,600Source | 2,400Source | 2,400Source | 2,400Source | 2,400Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -101,280Source | -184,078Source | -631,043Source | -513,104Source | -115,883Source | -343,258Source | -687,846Source | -921,983Source | -1,008,235Source | -2,380,870Source |
| Earnings Per Share, BasicUSD per share | — | — | — | — | -0.79Source | — | 0Source | — | -0.1Source | -0.13Source | -0.14Source | -0.33Source |
| Earnings Per Share, DilutedUSD per share | — | — | — | — | -0.79Source | — | 0Source | — | -0.1Source | -0.13Source | -0.14Source | -0.33Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 398,548,318Source | 398,548,318Source | 800,113Source | 398,548,318Source | 47,652,516Source | 398,548,318Source | 7,236,447Source | 7,236,447Source | 7,236,447Source | 7,235,609Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 398,548,318Source | 398,548,318Source | 800,113Source | 398,548,318Source | 47,652,516Source | 398,548,318Source | — | 7,236,447Source | 7,236,447Source | 7,235,609Source |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 2,400Source | 2,400Source | 2,400Source | 2,400Source |
| General and Administrative ExpenseUSD | — | — | — | — | 376,313Source | — | 28,300Source | — | 552,138Source | 695,788Source | 964,319Source | 1,579,065Source |
| Interest and Other IncomeUSD | — | — | 2,693Source | 8,433Source | 59Source | 3,343Source | 31Source | 5,691Source | 6Source | 5Source | 3,408Source | 33Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | 10,001Source | 6,954Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 2,554Source | -25,455Source | -983Source | -25,664Source | -4,076Source | -38,621Source | -69,327Source | -39,928Source | 393,933Source | 249,052Source |
| Operating ExpensesUSD | — | — | 103,834Source | 158,623Source | 628,460Source | 487,440Source | 111,807Source | 303,037Source | 616,119Source | 879,655Source | 1,399,768Source | 2,627,522Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Research and Development ExpenseUSD | — | — | — | — | 252,147Source | — | 83,507Source | — | 63,981Source | 183,867Source | 435,449Source | 1,048,457Source |
| Selling, General and Administrative Expense | — | — | —Source | —Source | — | —Source | — | —Source | — | — | — | — |
| Income (Loss) from Equity Method Investments | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |